Close

ViiV Healthcare to Acquire Bristol-Myers Squibb's (BMY) Investigational HIV Medicines Pipeline

December 18, 2015 6:35 AM EST Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced that it has entered into two individual agreements with ViiV Healthcare, a global HIV ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login